Fig. 4: Mean difference in PEF.
From: Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management
BID twice daily, CI confidence interval, LABA long-acting β2-agonist, LAMA long-acting muscarinic agonist, LTRA leukotriene receptor antagonist, NR not reported, NS non-significant, PEF peak expiratory flow, QD once daily.
